733 research outputs found

    Simulación con Monte Carlo para dosimetría de 153Samario-HM en un modelo anatómico geométrico de rodilla humana

    Get PDF
    El 153Sm-hm es una nueva opción para realizar sinovectomía por radiación, que actualmente se encuentra en valoración. Este trabajo tiene como objetivo calcular la dosis absorbida en tejidos articulares proporcionada por la administración de 153Sm-hm intraarticular, utilizando la simulación de Monte Carlo, en una propuesta de un modelo simplificado anatómico geométrico de la articulación de la rodilla. Esto con el propósito de aportar datos que apoyen la administración segura y eficaz del radiofármaco en estudio a pacientes con enfermedad reumática de la articulación de la rodilla. Se concluye que la actividad administrada de 153Sm-hm por vía intra-articular es de 370 MBq para conseguir una dosis absorbida en membrana sinovial de 110 Gy, considerada como la dosis de ablación de la mencionada membrana

    Preliminary clinical experience of the systemic use of 153Sm-EDTMP as a pain palliation agent in arthrosis and as an option for bone scanning in patients with bone metastases

    Get PDF
    Introducción: Muchos pacientes con artrosis tienen efectos secundarios producidos por los tratamientos convencionales. Estos pacientes son candidatos para tratamiento paliativo del dolor con 153Sm-EDTMP. Los pacientes con metástasis ósea, por lo general, requieren un rastreo utilizando ‘Tc-MDP, antes del tratamiento paliativo con 3Sm-EDTMP. Este trabajo tiene 2 objetivos: 1) evaluar el uso de 153Sm-EDTMP como alternativa en Los procedimientos de rastreo óseo en pacientes con metástasis ósea y, 2) si el 153Sm-EDTMP es captado en la articulación lesionada con artrosis, entonces se evalúa el uso eficiente y seguro de la administración sistémica de este radiofármaco, para Ia paliación del dolor por artrosis. Métodos y materiales: Una muestra no probabilística, de oportunidad y secuencial de 10 pacientes con artrosis fue seleccionada, así como, un paciente con metástasis ósea secundaria a cáncer de próstata. En Los 11 pacientes se realizaron gammagrafias óseas con Los radiofármacos “Tc-MDP y ls3mEDTMP, para comparar [a calidad de imagen y sitios de captación. En los pacientes con artrosis se administró por vía sistémica una dosis terapéutica de ‘Sm-EDTMP para la paliación del dolor. Se realizaron perfiles hematológicos con el fin de garantizar La seguridad de la médula ósea. La evolución del dolor y de la motilidad se utilizó para evaluar La eficacia analgésica 3Sm-EDTMR Resultados y conclusión: La calidad de imagen obtenida en Los 11 pacientes con ‘3Snì-EDTMP es similar desde el punto de vista clínico, a Ias obtenidas con ‘“Tc-MDR EL 3Sm-EDTMP es captado por las articulaciones con artrosis y metástasis óseas. La dosis terapéutica de 1’Sm-EDTMP administrada por vía intravenosa fue bien tolerada por Ia médula ósea en todos Los pacientes, así como hubo un efecto analgésico, por lo que mejoró la motilidad y la calidad de vida en los pacientes con artrosis.Introduction: Many patients with arthrosis have side effects produced by conventional treatments. These patients are candidates for pain palliation with 153Sm-EDTMP. Patients with cancer bone metastases usuaLly require a bone scanning procedure using ““Tc-MDP, prior to treatment through 153Sm-EDTMP. This work has two aims. Firstly, to assess the use of 153Sm- EDTMP as an alternative in bone scanning procedures in patients with bones metastases. Se condly, if the 153Sm-EDTMP is uptaken by the arthrosis injured joint, then the efficient and safe use of the systemic administration of this radiopharmaceutical is evaluated for pain palliation. Methods and materials: A non-probabilistic, of opportunity and sequential sample of 10 patients with arthrosis was selected, as well as, one patient with bone metastasis secondary to prostate cancer. In the li patients, bone scans were performed using both radiopharmaceuticals “‘T1Tc- MDP and 153Sm-EDTMP to compare image quality and uptake sites. In patients with arthrosis a therapeutic dose with ‘53Sm-EDTMP was systemically administered for pain palliation. Hemato logic profiles were performed in order to assure security to the bone marrow. Pain and motility evaluations were carried out to assess the Sm-EDTMP analgesic efficacy. Results and conclusion: The Image qualities obtained with 13Sm-EDTMP are similar from the cLinical point of view to those obtained with ““Tc-MDR Sm-EDTMP is captured by joints with arthrosis and bone metastases. Therapeutic doses of 1Sm-EDTMP intravenously administered are well tolerated by the bone marrow, while an analgesic effect is present which improves motility and quality of Life in patients with arthrosis

    Radiopharmacokinetics and uptake of 99m Tc-cRGD in av B3 integrins for imaging angiogenesis in induced malignant tumors in athymic mice

    Get PDF
    The multistep process of angiogenesis offers several targets for therapeutic interventions. One molecular target structure is the alfa five beta three (av b3 ) integrin which is expressed on vascular endothelial cells and over-expressed in cancer tumor angiogenesis. To image neoangiogenesis in athymic mice with induced pancreatic, breast and prostate malignant tumors a new radiopharmaceutical was developed. The 99mTc-EDDA/HYNIC-cyclic-Arg-Gly- Asp-D-Phe-Lys (99mTc-cRGD) targets integrin receptors av b3 and was prepared with an average radiochemical purity > 95 %. 99mTc-cRGD shows high in vivo stability, fast blood clearance and rapid renal excretion in mice. There are statistical differences between tumor/muscle ratios for the 3 tumors studied. The highest tumor/non-target ratio was found in breast cancer (7.2 after 24 h) and a representative dorsal SPECT image was obtained where the tumor showed up very clearly over the background tissue. The high resolution of the image implies that 99mTc-cRGD will be of great value in nuclear medicine as a potential radiopharmaceutical for av b3 integrins receptor uptake and for imaging neoangiogenesis in neoplastic tissue and to follow up cancer tumor progression

    Biodistribución y dosimetría interna de 68Ga-DOTA-UBI, radiofármaco para la evaluación específica de procesos infecciosos mediante PET

    Get PDF
    En los últimos años la medicina nuclear ha tenido un gran crecimiento gracias al desarrollo de nuevos radiofármacos para el diagnóstico de diversas patologías. En la Unidad Radiofarmacia-Ciclotrón de la Facultad de Medicina de la UNAM se desarrolló un radiofármaco para PET específico para procesos infecciosos utilizando un péptido catiónico antimicrobiano que se une a las membranas de las bacterias y es capaz de discriminar entre inflamaciones benignas de infecciones bacterianas

    Search for new particles in events with energetic jets and large missing transverse momentum in proton-proton collisions at root s=13 TeV

    Get PDF
    A search is presented for new particles produced at the LHC in proton-proton collisions at root s = 13 TeV, using events with energetic jets and large missing transverse momentum. The analysis is based on a data sample corresponding to an integrated luminosity of 101 fb(-1), collected in 2017-2018 with the CMS detector. Machine learning techniques are used to define separate categories for events with narrow jets from initial-state radiation and events with large-radius jets consistent with a hadronic decay of a W or Z boson. A statistical combination is made with an earlier search based on a data sample of 36 fb(-1), collected in 2016. No significant excess of events is observed with respect to the standard model background expectation determined from control samples in data. The results are interpreted in terms of limits on the branching fraction of an invisible decay of the Higgs boson, as well as constraints on simplified models of dark matter, on first-generation scalar leptoquarks decaying to quarks and neutrinos, and on models with large extra dimensions. Several of the new limits, specifically for spin-1 dark matter mediators, pseudoscalar mediators, colored mediators, and leptoquarks, are the most restrictive to date.Peer reviewe

    Combined searches for the production of supersymmetric top quark partners in proton-proton collisions at root s=13 TeV

    Get PDF
    A combination of searches for top squark pair production using proton-proton collision data at a center-of-mass energy of 13 TeV at the CERN LHC, corresponding to an integrated luminosity of 137 fb(-1) collected by the CMS experiment, is presented. Signatures with at least 2 jets and large missing transverse momentum are categorized into events with 0, 1, or 2 leptons. New results for regions of parameter space where the kinematical properties of top squark pair production and top quark pair production are very similar are presented. Depending on themodel, the combined result excludes a top squarkmass up to 1325 GeV for amassless neutralino, and a neutralinomass up to 700 GeV for a top squarkmass of 1150 GeV. Top squarks with masses from 145 to 295 GeV, for neutralino masses from 0 to 100 GeV, with a mass difference between the top squark and the neutralino in a window of 30 GeV around the mass of the top quark, are excluded for the first time with CMS data. The results of theses searches are also interpreted in an alternative signal model of dark matter production via a spin-0 mediator in association with a top quark pair. Upper limits are set on the cross section for mediator particle masses of up to 420 GeV

    Probing effective field theory operators in the associated production of top quarks with a Z boson in multilepton final states at root s=13 TeV

    Get PDF
    Peer reviewe

    Measurements of Higgs boson production cross sections and couplings in the diphoton decay channel at root s=13 TeV

    Get PDF
    Measurements of Higgs boson production cross sections and couplings in events where the Higgs boson decays into a pair of photons are reported. Events are selected from a sample of proton-proton collisions at root s = 13TeV collected by the CMS detector at the LHC from 2016 to 2018, corresponding to an integrated luminosity of 137 fb(-1). Analysis categories enriched in Higgs boson events produced via gluon fusion, vector boson fusion, vector boson associated production, and production associated with top quarks are constructed. The total Higgs boson signal strength, relative to the standard model (SM) prediction, is measured to be 1.12 +/- 0.09. Other properties of the Higgs boson are measured, including SM signal strength modifiers, production cross sections, and its couplings to other particles. These include the most precise measurements of gluon fusion and vector boson fusion Higgs boson production in several different kinematic regions, the first measurement of Higgs boson production in association with a top quark pair in five regions of the Higgs boson transverse momentum, and an upper limit on the rate of Higgs boson production in association with a single top quark. All results are found to be in agreement with the SM expectations.Peer reviewe

    Observation of tW production in the single-lepton channel in pp collisions at root s=13 TeV

    Get PDF
    A measurement of the cross section of the associated production of a single top quark and a W boson in final states with a muon or electron and jets in proton-proton collisions at root s = 13 TeV is presented. The data correspond to an integrated luminosity of 36 fb(-1) collected with the CMS detector at the CERN LHC in 2016. A boosted decision tree is used to separate the tW signal from the dominant t (t) over bar background, whilst the subleading W+jets and multijet backgrounds are constrained using data-based estimates. This result is the first observation of the tW process in final states containing a muon or electron and jets, with a significance exceeding 5 standard deviations. The cross section is determined to be 89 +/- 4 (stat) +/- 12 (syst) pb, consistent with the standard model.Peer reviewe

    Measurements of the Electroweak Diboson Production Cross Sections in Proton-Proton Collisions at root s=5.02 TeV Using Leptonic Decays

    Get PDF
    The first measurements of diboson production cross sections in proton-proton interactions at a center-of-mass energy of 5.02 TeV are reported. They are based on data collected with the CMS detector at the LHC, corresponding to an integrated luminosity of 302 pb(-1). Events with two, three, or four charged light leptons (electrons or muons) in the final state are analyzed. The WW, WZ, and ZZ total cross sections are measured as sigma(WW) = 37:0(-5.2)(+5.5) (stat)(-2.6)(+2.7) (syst) pb, sigma(WZ) = 6.4(-2.1)(+2.5) (stat)(-0.3)(+0.5)(syst) pb, and sigma(ZZ) = 5.3(-2.1)(+2.5)(stat)(-0.4)(+0.5) (syst) pb. All measurements are in good agreement with theoretical calculations at combined next-to-next-to-leading order quantum chromodynamics and next-to-leading order electroweak accuracy
    corecore